Cargando…

13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients

Background: This study aimed to evaluate the prognostic value of a non-invasive sampling procedure based on 13-gene DNA methylation analysis in the follow-up of patients previously treated for oral squamous cell carcinoma (OSCC). Methods: The study population included 49 consecutive patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Gissi, Davide B., Tarsitano, Achille, Gabusi, Andrea, Rossi, Roberto, Attardo, Giuseppe, Lenzi, Jacopo, Marchetti, Claudio, Montebugnoli, Lucio, Foschini, Maria P., Morandi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947392/
https://www.ncbi.nlm.nih.gov/pubmed/31810211
http://dx.doi.org/10.3390/jcm8122107
_version_ 1783485539975954432
author Gissi, Davide B.
Tarsitano, Achille
Gabusi, Andrea
Rossi, Roberto
Attardo, Giuseppe
Lenzi, Jacopo
Marchetti, Claudio
Montebugnoli, Lucio
Foschini, Maria P.
Morandi, Luca
author_facet Gissi, Davide B.
Tarsitano, Achille
Gabusi, Andrea
Rossi, Roberto
Attardo, Giuseppe
Lenzi, Jacopo
Marchetti, Claudio
Montebugnoli, Lucio
Foschini, Maria P.
Morandi, Luca
author_sort Gissi, Davide B.
collection PubMed
description Background: This study aimed to evaluate the prognostic value of a non-invasive sampling procedure based on 13-gene DNA methylation analysis in the follow-up of patients previously treated for oral squamous cell carcinoma (OSCC). Methods: The study population included 49 consecutive patients treated for OSCC. Oral brushing sample collection was performed at two different times: before any cancer treatment in the tumor mass and during patient follow-up almost 6 months after OSCC treatment, within the regenerative area after OSCC resection. Each sample was considered positive or negative in relation to a predefined cut-off value. Results: Before any cancer treatment, 47/49 specimens exceeded the score and were considered as positive. Six months after OSCC resection, 16/49 specimens also had positive scores in the samples collected from the regenerative area. During the follow-up period, 7/49 patients developed locoregional relapse: 6/7 patients had a positive score in the regenerative area after OSCC resection. The presence of a positive score after oral cancer treatment was the most powerful variable related to the appearance of locoregional relapse. Conclusion: 13-gene DNA methylation analysis by oral brushing may have a clinical application as a prognostic non-invasive tool in the follow-up of patients surgically treated for OSCC.
format Online
Article
Text
id pubmed-6947392
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69473922020-01-13 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients Gissi, Davide B. Tarsitano, Achille Gabusi, Andrea Rossi, Roberto Attardo, Giuseppe Lenzi, Jacopo Marchetti, Claudio Montebugnoli, Lucio Foschini, Maria P. Morandi, Luca J Clin Med Article Background: This study aimed to evaluate the prognostic value of a non-invasive sampling procedure based on 13-gene DNA methylation analysis in the follow-up of patients previously treated for oral squamous cell carcinoma (OSCC). Methods: The study population included 49 consecutive patients treated for OSCC. Oral brushing sample collection was performed at two different times: before any cancer treatment in the tumor mass and during patient follow-up almost 6 months after OSCC treatment, within the regenerative area after OSCC resection. Each sample was considered positive or negative in relation to a predefined cut-off value. Results: Before any cancer treatment, 47/49 specimens exceeded the score and were considered as positive. Six months after OSCC resection, 16/49 specimens also had positive scores in the samples collected from the regenerative area. During the follow-up period, 7/49 patients developed locoregional relapse: 6/7 patients had a positive score in the regenerative area after OSCC resection. The presence of a positive score after oral cancer treatment was the most powerful variable related to the appearance of locoregional relapse. Conclusion: 13-gene DNA methylation analysis by oral brushing may have a clinical application as a prognostic non-invasive tool in the follow-up of patients surgically treated for OSCC. MDPI 2019-12-02 /pmc/articles/PMC6947392/ /pubmed/31810211 http://dx.doi.org/10.3390/jcm8122107 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gissi, Davide B.
Tarsitano, Achille
Gabusi, Andrea
Rossi, Roberto
Attardo, Giuseppe
Lenzi, Jacopo
Marchetti, Claudio
Montebugnoli, Lucio
Foschini, Maria P.
Morandi, Luca
13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients
title 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients
title_full 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients
title_fullStr 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients
title_full_unstemmed 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients
title_short 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients
title_sort 13-gene dna methylation analysis from oral brushing: a promising non invasive tool in the follow-up of oral cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947392/
https://www.ncbi.nlm.nih.gov/pubmed/31810211
http://dx.doi.org/10.3390/jcm8122107
work_keys_str_mv AT gissidavideb 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT tarsitanoachille 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT gabusiandrea 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT rossiroberto 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT attardogiuseppe 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT lenzijacopo 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT marchetticlaudio 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT montebugnolilucio 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT foschinimariap 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients
AT morandiluca 13genednamethylationanalysisfromoralbrushingapromisingnoninvasivetoolinthefollowupoforalcancerpatients